Video laryngoscope sterilization protocols vary in detail across regions, but the underlying classification is consistent everywhere: a laryngoscope blade is a semi-critical device that requires, at minimum, high-level disinfection between patients. This guide compares how U.S. CDC guidance, UK professional body guidance that shapes NHS trust policy, and WHO’s global reprocessing framework each approach video laryngoscope sterilization, and what that means for departments choosing between reusable and single-use blade configurations.
Why laryngoscope blades are classified as semi-critical devices
Every sterilization protocol, in every country, starts with the same risk classification framework. The CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC) guideline applies the Spaulding classification system, which sorts reusable medical devices into three categories based on how they contact the patient, not on how visibly clean they appear.
Critical items contact sterile tissue and must be sterilized before use. Semi-critical items contact mucous membranes or non-intact skin and require, at minimum, high-level disinfection. Non-critical items only contact intact skin and require only low-level disinfection. Laryngoscope blades, along with respiratory therapy and anaesthesia equipment, flexible endoscopes, and cystoscopes, fall into the semi-critical category because they contact the mucous membranes of the airway during use.
This classification applies regardless of whether the blade is video-enabled or a traditional direct laryngoscope. The camera and monitor do not change the anatomical contact the blade makes with the patient. A reusable video laryngoscope blade is a semi-critical device with exactly the same reprocessing obligation as a traditional Macintosh blade.
What CDC and U.S. guidance require
High-level disinfection, per the CDC guideline, destroys all microorganisms except high numbers of bacterial spores, sitting between full sterilization and lower-level disinfection that cannot reliably eliminate resistant organisms. FDA-cleared high-level disinfectants commonly used for this purpose include glutaraldehyde, hydrogen peroxide, ortho-phthalaldehyde, and peracetic acid with hydrogen peroxide.
The Joint Commission has specifically addressed laryngoscope blade processing, noting that whenever possible, facilities should use steam sterilization by autoclaving, or high-level disinfection by wet heat pasteurization above 158°F (70°C) for 30 minutes, for reprocessing semi-critical equipment that is not heat- or moisture-sensitive. Low-temperature sterilization methods approved by the FDA are used for equipment that is heat- or moisture-sensitive, which is the relevant category for most video laryngoscope blades with integrated electronics.
Despite this clear guidance, compliance gaps persist. A 2025 study published in the American Journal of Infection Control documented a hospital protocol that involved only cleaning laryngoscopes with running water, neutral soap, and a soft brush, followed by wiping with 70% alcohol, a process the study’s commentary noted is acceptable for non-critical items but does not meet the high-level disinfection standard required for a semi-critical device. This is not an isolated finding. Industry commentary has repeatedly noted that many facilities still only hand-wash blades and perform low-level disinfection, despite the semi-critical classification being well established.
What UK guidance requires and how NHS trusts implement it
In the UK, video laryngoscope decontamination is not governed by a single standalone “NHS guideline” document. Instead, NHS trusts implement infection prevention and control policy that is informed by professional body guidance, principally from the Association of Anaesthetists (formerly AAGBI), combined with national infection prevention frameworks.
The Association of Anaesthetists’ safety guidelines on infection prevention and control, most recently updated in 2020, set out the current UK professional standard. Earlier Association guidance had already established that laryngoscope blades are regularly contaminated with blood, indicating penetration of mucous membranes, which places them in a high-risk category, and concluded that the use of single-use blades is to be encouraged.
More recent developments have pushed UK policy further in this direction. A 2022 evaluation published in the British Journal of Anaesthesia noted that recent Association of Anaesthetists guidelines and a Welsh infection control policy specify that laryngoscope handles and blades must be either single-use or suitable for fully automated decontamination. This is a materially stricter standard than the CDC’s minimum requirement, since it effectively excludes manual high-level disinfection as an acceptable long-term reprocessing method for reusable blades in that jurisdiction.
This UK trend matters directly for departments evaluating video laryngoscope systems, since it signals a regulatory direction that other jurisdictions may follow: a shift from “high-level disinfection is acceptable” toward “automated decontamination or single-use is required.”
What WHO’s global reprocessing framework establishes
The World Health Organization does not publish device-specific laryngoscope guidance in the way CDC and the Association of Anaesthetists do. Instead, WHO defines medical device reprocessing at a framework level as the procedures required to prepare a contaminated reusable device for its intended use, encompassing cleaning, packaging, labelling, disinfection, and sterilisation as distinct steps.
Within that WHO framework, laryngoscopes are classified as semi-critical items requiring at least high-level disinfection, aligning with both the CDC and the Association of Anaesthetists’ position. WHO’s framework additionally emphasises that high-level disinfection should be preceded by thorough cleaning to remove organic material, since disinfectant efficacy depends on the device being physically clean first, not just chemically treated.
Sustainability considerations are increasingly part of this global conversation. Moist heat sterilization in a central sterilisation department is time- and resource-intensive, requiring significant water consumption even when equipment is idle, and is limited to heat-resistant objects. This has driven interest in alternative reprocessing methods. A 2026 laboratory evaluation published in the BJA Open assessed ultraviolet-C LED disinfection for reprocessing disposable video laryngoscope blades and found that automated UV-C treatment effectively disinfected the blades under controlled laboratory conditions, preserving material integrity while offering environmental and economic advantages over single-use replacement and conventional autoclaving.
What these three frameworks mean when compared directly
Despite differences in specificity and enforcement mechanisms, the three frameworks agree on the fundamental classification and disagree mainly on how strictly the reprocessing method is prescribed.
CDC and U.S. practice set high-level disinfection as the accepted minimum standard, with sterilization preferred where practical, but leave the specific reprocessing method largely to institutional protocol as long as validated high-level disinfection is achieved.
UK guidance, through the Association of Anaesthetists and increasingly reflected in NHS trust and devolved health policy such as the Welsh infection control policy, has moved toward a stricter position: reusable blades must be either single-use or suitable for fully automated decontamination, effectively discouraging manual high-level disinfection as a long-term practice.
WHO provides the underlying global framework and terminology that both the CDC and UK approaches sit within, without prescribing a specific reprocessing method, leaving that detail to national and regional bodies while affirming the semi-critical classification and the cleaning-before-disinfection principle universally.
What this means for departments choosing between reusable and single-use blades
The practical implication of comparing these three frameworks is that the regulatory direction, particularly in the UK, is trending toward automated or single-use solutions rather than manual reprocessing. A department relying on manual high-level disinfection for reusable blades should treat this as a compliance area to monitor closely, not a settled practice.
This does not mean reusable blades are being phased out. Automated decontamination systems and validated high-level disinfection remain acceptable under CDC guidance and under the Association of Anaesthetists standard when fully automated. What it does mean is that a department’s reprocessing method matters as much as its choice of reusable versus disposable blades. A reusable blade system paired with a validated automated decontamination process meets the strictest current standards. A reusable blade system relying on manual disinfection is increasingly out of step with where UK guidance, and potentially future guidance elsewhere, is heading.
For departments weighing this trade-off directly, particularly in high-turnover settings like the ED, see our guide on single-use video laryngoscope blades and when disposable is the right choice. For a broader breakdown of ED-specific procurement criteria, including sterilization considerations, see our buyer’s guide to video laryngoscopes for emergency departments.
What Astra-vue offers across this compliance landscape
Astra-vue’s product range is built to give departments flexibility across this regulatory spectrum rather than forcing a single reprocessing approach. The reusable Ultra Blade range carries an IP67 waterproof rating, supporting the immersion-based high-level disinfection and automated decontamination protocols required under both CDC and Association of Anaesthetists guidance. The disposable Lite and Pro Blade ranges remove the reprocessing question entirely for departments that prefer, or are moving toward, single-use as their primary infection control strategy.
Both blade types run on the same universal monitor platform, which means a department can align its reprocessing approach with its local regulatory environment, whether that means validated automated decontamination for reusable blades or a shift toward single-use, without needing separate equipment. For the operational case behind running both configurations on one platform, see our guide on why a universal video laryngoscope monitor platform reduces hospital equipment complexity.
For guidance on which sterilization or single-use configuration fits your department’s regulatory environment and case mix, contact our team or explore the full product line.
Frequently asked questions about video laryngoscope sterilization protocols
Are video laryngoscope blades classified differently from traditional laryngoscope blades for sterilization purposes?
No. The Spaulding classification used by CDC, the Association of Anaesthetists, and WHO all classify laryngoscope blades as semi-critical devices based on their contact with mucous membranes, regardless of whether the blade includes video and camera technology. A reusable video laryngoscope blade carries the same minimum high-level disinfection requirement as a traditional direct laryngoscope blade.
What is the minimum acceptable sterilization method for a reusable video laryngoscope blade?
Under CDC guidance, high-level disinfection is the accepted minimum, with steam sterilization by autoclaving preferred where the device is heat-tolerant. Under current UK Association of Anaesthetists guidance and policies such as Wales’s infection control policy, reusable blades must be either single-use or suitable for fully automated decontamination, a stricter standard than manual high-level disinfection alone.
Is UK guidance on video laryngoscope sterilization stricter than U.S. guidance?
In practice, yes, at least in the direction UK guidance is currently heading. While both CDC and the Association of Anaesthetists agree on the semi-critical classification and the high-level disinfection minimum, recent Association of Anaesthetists guidance and devolved UK health policy have moved toward requiring single-use blades or fully automated decontamination, effectively discouraging manual high-level disinfection as an acceptable long-term reprocessing method.
Does WHO publish specific laryngoscope sterilization requirements?
WHO does not publish device-specific laryngoscope sterilization protocols in the way CDC and the Association of Anaesthetists do. Instead, WHO defines a general medical device reprocessing framework covering cleaning, packaging, labelling, disinfection, and sterilisation, within which laryngoscopes are classified as semi-critical items requiring at least high-level disinfection, consistent with both the CDC and UK positions.
Should a department switch entirely to single-use blades based on these guidelines?
Not necessarily. Automated decontamination systems paired with reusable blades remain an acceptable reprocessing method under all three frameworks. The key compliance risk is manual high-level disinfection without automation, which is increasingly out of step with current UK guidance. A department with validated automated decontamination infrastructure can continue using reusable blades compliantly, while departments without that infrastructure should weight their evaluation toward single-use configurations.
